VYNE Therapeutics
VYNE
#10150
Rank
โ‚ฌ16.99 M
Marketcap
0,51ย โ‚ฌ
Share price
48.99%
Change (1 day)
-79.70%
Change (1 year)

VYNE Therapeutics (VYNE) - Total debt

Total debt on the balance sheet as of September 2025 : N/A

According to VYNE Therapeutics's latest financial reports the company's total debt is N/A. A companyโ€™s total debt is the sum of all current and non-current debts.

VYNE Therapeutics - Total debt on balance sheet (from 2018 to 2025)

Total debt by year

Year Total debt Change
2024-12-31โ‚ฌ0.09 M-50.86%
2023-12-31โ‚ฌ0.19 M
2022-12-31N/A-100%
2021-12-31โ‚ฌ0.3 M-98.91%
2020-12-31โ‚ฌ28.27 M4425.71%
2019-12-31โ‚ฌ0.62 M
2018-12-31N/A

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
ORIC Pharmaceuticals
ORIC
โ‚ฌ2.8 MN/A๐Ÿ‡บ๐Ÿ‡ธ USA